Searchable abstracts of presentations at key conferences on calcified tissues

ba0003pp253 | Osteoporosis: evaluation and imaging | ECTS2014

Bone mass in HIV male patients undergoing antiretroviral therapy

Moro-Alvarez Maria-Jesus , Ryan-Murua Pablo , Troya-Garcia Jesus , Solis-Villa Francisco-Javier , Villa-Azpeitia-Arman Francisco-Javier

Multiple factors of risk have been described to the osteoporosis (OSP) and fractures in people infected by human immunodeficiency virus (HIV). Antiretroviral treatment has changed the vital prognosis of these patients, nevertheless seems that antiretroviral treatments can cause a greater loss of bone mineral density (BMD). Experts support the use of densitometry screening for HIV-infected postmenopausal women and men older than 50 years.Objectives: To ev...

ba0004op9 | (1) | ICCBH2015

Growth, body mass index, bone health and ambulatory status of boys with Duchenne Muscular Dystrophy treated with daily vs intermittent oral glucocorticoid regimen

Crabtree Nicola , Padidela Raja , Shaw Nicholas , Hogler Wolfgang , Roper Helen , Hughes Imelda , Adams Judith , Daniel Anjali , Mughal Zulf

Background: Oral glucocorticoids (GC; prednisolone dose of 0.75 mg/kg per day), help to preserve muscle strength and prolong independent walking in boys with DMD. This study compared longitudinal growth, body mass index (BMI), bone mineral density (BMD), vertebral fractures (VFs) and ambulatory status in boys with DMD on daily (DAILY) or intermittent (INTER; 10 days on & 10 days off), oral GC regimens.Methods: 50 DMD boys from two UK centres were inc...

ba0004p4 | (1) | ICCBH2015

Bone turnover markers and bone mineral density after 12-month weight loss therapy in obese children

Gajewska Joanna , Klemarczyk Witold , Ambroszkiewicz Jadwiga , Chelchowska Magdalena , Weker Halina

Objectives: Weight loss therapy is the principal non-pharmacological method for prevention and treatment of simple obesity in childhood. This intervention may influence bone metabolism in children, but this phenomenon is not well understood. The aim of this study was to assess the changes in body composition and in the profile of bone markers after weight loss in obese prepubertal children.Methods: We determined serum BALP (bone alkaline phosphatase), CT...

ba0004p27 | (1) | ICCBH2015

Bone mineral density and clinical outcome after intravenous bisphosphonate discontinuation in children with osteogenesis imperfecta

Bowden Sasigarn , Heksch Ryan , Hickey Scott , Mahan John

Objectives: i) To evaluate the bone mineral density (BMD), and clinical outcomes of intravenous bisphosphonate treatment (IVT) and after treatment discontinuation in children with osteogenesis imperfecta (OI). ii) To compare the clinical outcome of those who discontinued IVT and those who had progressed from IVT to maintenance oral bisphosphonate therapy.Methods: A retrospective study was conducted on 28 children with OI who had discontinued IVT (21 pami...

ba0004p35 | (1) | ICCBH2015

Spinal muscular atrophy: another non-ambulatory population at risk for low bone mineral density

Kecskemethy Heidi , Bachrach Steven , Harcke H Theodore

In children with spinal muscular atrophy (SMA): i) describe bone mineral density (BMD) measured by dual-energy x-ray absorptiometry (DXA); ii) examine bone health factors; iii) examine change in BMD over time and pamidronate effect.DXA results, medications, ambulation, 25-OH-Vit D levels, and fracture history were retrospectively reviewed in 14 children (five girls) with SMA. Sites scanned included whole body (WB), lumbar spine (LS), and lateral distal f...

ba0004p39 | (1) | ICCBH2015

Fracture and bone mineral density outcomes after bisphosphonate discontinuation in children with osteogenesis imperfecta treated with zoledronic acid compared to pamidronate

Heksch Ryan , Bowden Sasigarn , Hickey Scott , Mahan John

Objectives: Cyclical intravenous pamidronate (PAM) and zoledronic acid (ZOL) increases bone mineral density (BMD) and reduces fractures in children with osteogenesis imperfecta (OI). The aims of this study were to evaluate fracture and BMD outcomes after treatment discontinuation in children with OI treated with ZOL compared to PAM.Methods: 21 patients (mean age 5.1±3.8 years) received PAM (1 mg/kg per day x 3 days q 3 months for the first year). Se...

ba0004p115 | (1) | ICCBH2015

Vitamin D and bone mineral density in children with Duchenne muscular dystrophy relation to fractures and ambulation status

Buckner Jason , Bowden Sasigarn

Objectives: To evaluate vitamin D and bone mineral density (BMD) status in children with Duchene muscular dystrophy (DMD) in relation to fractures and ambulation status using gross motor scale function classification system (GMFCS).Methods: Clinical data of 53 DMD patients (mean age 12.1 years, range 4.9–19.6) at the first visit to the Endocrine/Bone Clinic at Nationwide Children’s Hospital were retrospectively studied. The patients were strati...

ba0004p134 | (1) | ICCBH2015

Associations of 25-hydroxyvitamin D with major components of metabolic syndrome in children

Challa Anna , Evagelidou Eleni , Siomou Ekaterini , Tzallas Alexandros , Giapros Vasileios

Objective: To study any possible relations of vitamin D status and metabolic syndrome (MetS) components in children, since there is evidence for extraskeletal functions of vitamin D, and its deficiency may contribute to the pathogenesis of several major diseases. In addition to explore any possible role of birth weight (BW).Methods: Clinically healthy children aged 3–9 years (n=152) were included in the study. Forty-six were born large for ...

ba0004p185 | (1) | ICCBH2015

The effect of iron chelators on bone health in patients with thalassemia

Fung Ellen , Luo Nan , Gildengorin Ginny , Lal Ashutosh

Thalassemia (Thal) is a genetic disorder of hemoglobin synthesis. In its most severe form patients require chronic blood transfusions to sustain life leading to iron overload unless excess iron is removed by chelators. Deferasirox (DFX) and deferoxamine (DFO) are the two most common chelators. DFX has recently been shown to reduce osteoclast activity in vitro.Objective: To explore the association between chelation therapy, bone density and verte...

ba0005p225 | Energy metabolism and bone, fat and bone | ECTS2016

Association between bone turnover markers and leptin in girls with adolescent idiopathic scoliosis (AIS)

Matusik Edyta , Durmala Jacek , Olszanecka-Glinianowicz Magdalena , Chudek Jerzy , Matusik Pawel

The link between scoliotic deformity and bone metabolism in adolescent idiopathic scoliosis (AIS) has not been well researched. Moreover, the data concerning the cross-talk between leptin level and bone markers in this group of patients are lacking. The objective of this study was to correlate the extent of scoliotic-curve severity with the bone turnover and leptin level in girls with AIS. The study encompassed 77 AIS girls, aged 14.7±2.17 years. Scoliotic curve severity ...